Research

Pharmacogenomics

Policy 0107

03/01/2001 Introduced
11/01/2005 Reapproved
11/01/2009 Revised
02/01/2014 Revised

02/21/2018 Reapproved

AMCP supports further research and assessment of the economic, clinical, and humanistic impact of pharmacogenomics on managed care pharmacy practice. AMCP supports the pharmacist's leadership role in the review and evaluation of scientific evidence and the subsequent development of pharmaceutical care processes involving these therapies through collaboration with other health care practitioners and consumer organizations. Pharmacy and Therapeutics Committees in collaboration with Health Technology Assessment committees should be involved in the decision-making process related to coverage of genetic tests and utilization management strategies. 

Related